
The NHS is authorised to use its first two cannabis-based medicines for routine use after NICE saw fit to recommend …

UK-based GW Pharma has suffered a setback in its home country after drug watchdog NICE chose not to recommend NHS …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

